Altered maternal micronutrients (folic acid, vitamin B 12) and omega 3 fatty acids through oxidative stress may reduce neurotrophic factors in preterm pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 4, 2012, Pages 317-323

  Dhobale, Madhavi ^a   Joshi, Sadhana ^a  

^a Bharati Vidyapeeth Deemed University   (India)

Author keywords

behavioural disorders; docosahexaenoic acid; Epigenetics; neurotrophins; pregnancy complications

Indexed keywords

ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; LINOLEIC ACID; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; OMEGA 3 FATTY ACID;

BRAIN DEVELOPMENT; EPIGENETICS; FETUS GROWTH; FETUS OUTCOME; FETUS RISK; HUMAN; LIPID PEROXIDATION; MATERNAL NUTRITION; NUTRIENT CONTENT; NUTRITIONAL DISORDER; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; OXIDATIVE STRESS; PLACENTA DEVELOPMENT; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; VITAMIN SUPPLEMENTATION;

ANIMALS; EPIGENESIS, GENETIC; FATTY ACIDS, OMEGA-3; FEMALE; FOLIC ACID; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICRONUTRIENTS; MODELS, BIOLOGICAL; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; VITAMIN B 12;

EID: 84858667364     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.579209     Document Type: Review

References (34)

1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90. (Pubitemid 15192138)
2. World Health Organization Report: World Health Statistics. Geneva: World Health Organization; 2006.
3. King JC. Physiology of pregnancy and nutrient metabolism. Am J Clin Nutr 2000;71:1218S-1225S. (Pubitemid 30230521)
4. Ramakrishnan U, Manjrekar R, Rivera J, Gonzales-Cossio T, Martorell R. Micronutrients and pregnancy outcome: A review of the literature. Nutr Res 1999;19:103-159. (Pubitemid 29019610)
5. Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S, Joshi S. Fatty acids, antioxidants and oxidative stress in pre-eclampsia. Int J Gynaecol Obstet 2008;100:234-238. (Pubitemid 351258086)
6. Kilari A, Mehendale S, Dangat K, Yadav HR, Gupta A, Taralekar VS, Joshi SR. Long chain polyunsaturated fatty acids in mothers of preterm babies. J Perinat Med 2010;38:659-664.
7. Joshi SR, Mehendale SS, Dangat KD, Kilari AS, Yadav HR, Taralekar VS. High maternal plasma antioxidant concentrations associated with preterm delivery. Ann Nutr Metab 2008;53:276-282.
8. Antony AC. In utero physiology: Role of folic acid in nutrient delivery and fetal development. Am J Clin Nutr 2007;85:598S- 603S. (Pubitemid 46220968)
9. McKay JA, Williams EA, Mathers JC. Folate and DNA methylation during in utero development and aging. Biochem Soc Trans 2004;32:1006-1007. (Pubitemid 39655528)
10. Picker JD, Coyle JT. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry 2005;13:197-205. (Pubitemid 41437571)
11. Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004;62:S3-S12.
12. Roth TL, Lubin FD, Sodhi M, Kleinman JE. Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 2009; 1790:869-877.
13. Rao S, Joshi S, Kale A, Hegde M, Mahadik S. Maternal folic acid supplementation to dams on marginal protein level alters brain fatty acid levels of their adult offspring. Metabolism 2006;55:628-634.
14. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:804S- 819S.
15. Haggarty P. Fatty acid supply to the human fetus. Annu Rev Nutr 2010;30:237-255.
16. Su HM.Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 2010;21:364-373.
17. Nettleton JA. Are n - 3 fatty acids essential nutrients for fetal and infant development? J Am Diet Assoc 1993;93:58-64. (Pubitemid 23019610)
18. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008;29:S116-S125.
19. Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 2005;289:H2649-H2656. (Pubitemid 41699830)
20. Joshi SR, Mehendale SS, Dangat KD, Kilari AS, Yadav HR, Taralekar VS. High maternal plasma antioxidant concentrations associated with preterm delivery. Ann Nutr Metab 2008;53:276-282.
21. Roy S, Kale A, Dangat K, Sable P, Kulkarni A, Joshi S. Maternal micronutrients (folic acid and vitaminB12) and omega 3 fatty acids: Implication for neurodevelopment risk in the rat offspring. Brain Dev, in press.
22. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, et al. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011;35:804-817.
23. Sizonenko SV, Bednarek N, Gressens P. Growth factors and plasticity. Semin Fetal Neonatal Med 2007;12:241-249. (Pubitemid 46875054)
24. Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) 2006;110:175-191. (Pubitemid 43241479)
25. Skaper SD. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 2008;7:46-62. (Pubitemid 351516216)
26. Kale A, Joshi S, Naphade N, Sapkale S, Raju MS, Pillai A, Nasrallah H, Mahadik SP. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients. Schizophr Res 2008;98:295-301. (Pubitemid 350245596)
27. Kale A, Joshi S, Naphade N, Sapkale S, Raju MS, Pillai A, Nasrallah H, Mahadik SP. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism. Schizophr Res 2008;98:295-301.
28. Kale A, Joshi S, Pillai A, Naphade N, Raju M, Nasrallah H, Mahadik SP. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. Schizophr Res 2009;115:209-214.
29. Malamitsi-Puchner A, Economou E, Rigopoulou O, Boutsikou T. Perinatal changes of brain-derived neurotrophic factor in preand fullterm neonates. Early Hum Dev 2004;76:17-22. (Pubitemid 38058792)
30. Chouthai NS, Sampers J, Desai N, Smith GM. Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr Res 2003;53:965-969. (Pubitemid 36666996)
31. Shum D, Neulinger K, O'Callaghan M, Mohay H. Attentional problems in children born very preterm or with extremely low birth weight at 7-9 years. Arch Clin Neuropsychol 2008;23:103-112. (Pubitemid 350309495)
32. Doyle LW, Anderson PJ. Adult outcome of extremely preterm infants. Paediatrics 2010;126:342-351.
33. Bhate V, Deshpande S, Bhat D, Joshi N, Ladkat R, Watve S, Fall C, de Jager CA, Refsum H, Yajnik C. Vitamin B12 status of pregnant Indian women and cognitive function in their 9-year-old children. Food Nutr Bull 2008;29:249-254.
34. Kawamura K, Kawamura N, Sato W, Fukuda J, Kumagai J, Tanaka T. Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology 2009;150: 3774-3782.